Vyvgart’s approval is based on the data obtained from the global Phase III ADAPT...
Despite advancing research, clinical data and timely reimbursement are crucial f...
GlobalData analysts detail a rise in risk sharing agreements with pharma compani...
The partnership is intended to request proposals for research grants focused on ...
Ghryvelin is used for the diagnosis of Adult Growth Hormone Deficiency.
The abrupt closure of Ketamine Wellness Centers is one of the bigger upheavals i...
Moderna CEO Stéphane Bancel made $398 million in 2022. Most of that, according t...
From new hires to departures, promotions, and transfers, here are the latest com...
FDA Commissioner Robert Califf wants private insurers to chip in on doing post-a...
STAT sat down with Kirsten Bibbins-Domingo to learn more about the changes she’s...
Researchers want to use AI to better predict the need for C-sections — and give ...
The already beleaguered U.S. health care system is facing a new and costly threa...
Experts have long understood that a new polio vaccine developed to try to minimi...
Medicaid officials are working unusually closely with states as the pandemic-era...
In a sudden about-face, the Food and Drug Administration will hold a meeting of ...
Sanofi has become the latest insulin maker to cut list prices in response to mou...
